Research progress of SMIM1 in Vel blood type, tumor and plasmodium infection
10.13303/j.cjbt.issn.1004-549x.2023.05.021
- VernacularTitle:SMIM1在Vel血型、肿瘤和疟原虫感染中的研究进展
- Author:
Pan XIAO
1
;
Yulin LIU
1
;
Deqing WANG
2
Author Information
1. Department of Transfusion Medicine, the First Medical Center, Chinese PLA General Hospital, Beijing 100039, China; College of Clinical Medicine, Southwest Medical University
2. Department of Transfusion Medicine, the First Medical Center, Chinese PLA General Hospital, Beijing 100039, China
- Publication Type:Journal Article
- Keywords:
SMIM1;
Vel blood group antigen;
tumor biomarkers;
malaria
- From:
Chinese Journal of Blood Transfusion
2023;36(5):459-462
- CountryChina
- Language:Chinese
-
Abstract:
Small integral membrane protein 1(SMIM1) gene encodes Vel blood group antigen, and homozygous deletion of 17 bases pairs in its exon 3 leads to Vel negative phenotype. As a rare phenotype, accurate identification and prevention of transfusion reaction for Vel negative phenotype is particularly important. In addition to serving as a Vel blood group antigen, recent bioinformatics analysis suggests that SMIM1 protein may be a new tumor biomarker involved in the occurrence and development of numerous tumors. Due to the similarity in structure between SMIM1 protein and glycoprotein, and its phosphorylation in red blood cells infected with Plasmodium falciparum, it is speculated that SMIM1 protein may be involved in the development of malaria. Therefore, this article provides a review of the related research on SMIM1 and its coding protein in Vel blood type, tumor and plasmodium infection.
